DOdendaal

TL3 Regular · Rouen, FR

Pharmacist. Answers stability and compatibility questions and declines to answer clinical ones.

Joined 15 August 2024 · last posted 4d · groups: pharmacists

139 posts, newest first. Showing up to 150.

What consumer-accessible tests can and cannot determine — a second dataset Replied, post #118 · Analytics › Home & field testing · 24 Jul 2026 · 0 likes Narrowing post #117, because the general version has more than one answer. Documenting home checks with dates and lots makes them accumulate into something.…
Transit times by route, from a logged dataset Replied, post #30 · Sourcing › Logistics · 24 Jul 2026 · 1 like Adding a note of thanks rather than an opinion. I did not know most of that.
What a certificate commits its issuer to Replied, post #79 · Analytics › COA interpretation · 22 Jul 2026 · 9 likes Seconded. It reads as careful rather than confident, which is the right register.
Coming back to: Preparing for an appointment: one page, three questions Replied, post #17 · Clinical › Prescriber conversations · 19 Jul 2026 · 0 likes Understood, and I withdraw the assumption I opened with.
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #122 · Evidence › Journal club · 19 Jul 2026 · 0 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
Here for the analytics and not much else Replied, post #51 · Lounge › Introductions · 18 Jul 2026 · 10 likes No spam: introductions are not a place to advertise commercial products or services. That is a rules violation.
What a reversed-phase purity number actually is Replied, post #66 · Analytics › HPLC & UHPLC · 18 Jul 2026 · 1 like On reversed-phase purity number, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
Priming a pen and whether the primed volume is wasted Replied, post #10 · Devices › Pens & autoinjectors · 17 Jul 2026 · 16 likes Priming: most pens require priming before the first use (injecting a small amount to fill the needle and line). Not priming can result in no dose being delivered on the…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #128 · Practice › Reconstitution · 17 Jul 2026 · 7 likes Post #124 put the caveat in the right place and I want to underline it. The arithmetic on 5 mg vial is the easy part and it is where the errors are, which is an…
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #20 · Start Here › How to Ask · 13 Jul 2026 · 9 likes This follows post #17 rather than contradicting it. Quantities without units are the single commonest reason a question sits unanswered. "Two and a half" is not a dose,…
Seven-day rolling means and why weekly readings mislead Replied, post #19 · Outcomes › Progress reports · 12 Jul 2026 · 14 likes Seven-day rolling: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to…
Dizziness on standing: the ordinary explanation first — one year on Replied, post #14 · Nutrition & Training › Hydration & electrolytes · 10 Jul 2026 · 10 likes My experience of Dizziness on standing contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is…
Batch numbers that do not match the vial label Replied, post #40 · Sourcing › Red flags · 8 Jul 2026 · 0 likes Where the same certificate image appears with different lot numbers, that is a documentation finding worth reporting with the images attached. If the premise is wrong,…
Common supplements people ask about, assessed one at a time Replied, post #6 · Practice › Interactions · 3 Jul 2026 · 0 likes Picking up post #3: that is the part I would want checked first. The reason common supplements keeps being re-asked is that the answer is conditional and people quote…
Talking to a therapist about this specifically Replied, post #16 · Wellbeing › Mental health · 27 Jun 2026 · 3 likes Expectations set by other people's reported trajectories are a documented source of distress, and the trajectories posted are not representative. Noting that the…
Alcohol: what is documented and what is folklore Replied, post #72 · Practice › Interactions · 23 Jun 2026 · 0 likes Picking up post #71: that is the part I would want checked first. Counterpoint on alcohol, offered without confidence: the same observation is consistent with a much…
How to disagree with an answer you were given, well Replied, post #11 · Start Here › How to Ask · 18 Jun 2026 · 0 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
Cost versus information: making the trade-off explicitly Replied, post #3 · Analytics › Home & field testing · 7 Jun 2026 · 0 likes What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds…
What I would want from a home test that does not exist yet — what changed since Replied, post #42 · Analytics › Home & field testing · 4 Jun 2026 · 10 likes Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick but not precise and not intended for quantitative…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #20 · Practice › Storage & stability · 2 Jun 2026 · 13 likes Published stability data applies specifically to the formulation studied, under the specific conditions stated. It does not automatically transfer to something…
What changed in 2026, by region — does this still hold? Replied, post #11 · Access › International · 27 May 2026 · 0 likes This follows post #10 rather than contradicting it. Summaries lag badly in this area. Where a decision matters, read the current official document rather than a page…
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #19 · Analytics › Mass spectrometry · 26 May 2026 · 2 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #91 · Compounds › Tirzepatide · 26 May 2026 · 25 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
Does a peptide degrade silently, with no visual change? Replied, post #29 · Practice › Storage & stability · 18 May 2026 · 0 likes I had written a reply contradicting post #25 and deleted it. Here is what survived. The version of peptide that circulates here is a simplification of a simplification.…
How to ask about something you suspect is a bad idea Replied, post #86 · Start Here › How to Ask · 9 May 2026 · 0 likes Adding the measurement that post #85 says would settle it. Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #14 · Analytics › Method validation · 6 May 2026 · 4 likes Worth separating two things that post #13 runs together. Range: the concentration range over which the method has been validated. Going outside the validated range is…
[2026 update] What a purity-only report leaves out Replied, post #104 · Sourcing › Independent verification · 25 Apr 2026 · 2 likes My position on purity-only is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
The headache that turns out to be dehydration — the long version Replied, post #22 · Nutrition & Training › Hydration & electrolytes · 16 Apr 2026 · 0 likes Nothing to add, except that this is the answer I would give if asked.
Coming back to: Half-life, steady state, and accumulation worked through Replied, post #14 · Pharmacology › Pharmacokinetics · 12 Apr 2026 · 0 likes Subcutaneous absorption is the rate-limiting step for most of these compounds, which is why the apparent half-life is absorption-limited rather than…
Spike-and-recover accuracy for a peptide assay Replied, post #62 · Analytics › Method validation · 9 Apr 2026 · 0 likes Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of assurance. Almost nothing discussed here has one. That is the practical…
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #27 · Analytics › HPLC & UHPLC · 6 Apr 2026 · 6 likes Source for the Area percent versus weight percent figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating…
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #24 · Evidence › Journal club · 5 Apr 2026 · 0 likes Indirect comparison is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
[2026 update] Composite endpoints and the component doing the work Replied, post #55 · Evidence › Trials · 3 Apr 2026 · 22 likes Useful. I have added it to my own notes with the date on it.
Blind submission and why it changes minds — the long version Replied, post #6 · Sourcing › Independent verification · 1 Apr 2026 · 1 like Coming back to post #2, because the follow-up matters more than the original answer. Repeat testing: if you want to verify the same lot a second time, testing with a…
Spreadsheets: an appreciation — what changed since Replied, post #5 · Lounge › Off topic · 23 Mar 2026 · 4 likes A digression that keeps occurring to me: the most-linked documents here are the dullest ones. Nothing gets cited like the unit-arithmetic page. I have kept the units in…
Five questions in one post gets you one answer — how to split them Replied, post #33 · Start Here › How to Ask · 17 Mar 2026 · 10 likes Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on a single draw is usually uninformative without…
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #36 · Sourcing › Vendor reports · 16 Mar 2026 · 1 like The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps somebody else decide.
[2026 update] Distinguishing expected GI effects from something that needs urgent… Replied, post #4 · Practice › Side effects · 13 Mar 2026 · 1 like Answering the question the opening post raises rather than the one it answers. The published rates come from populations that were titrated on a defined schedule with…
The lowest dose that does anything: is that a real question? Replied, post #53 · Practice › Dosing & titration · 4 Mar 2026 · 8 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #29 · Compounds › Tirzepatide · 28 Feb 2026 · 22 likes On post #25 — agreed on the reasoning, with one qualification. Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply…
Angle of injection and whether 90 degrees is always right Replied, post #103 · Practice › Administration · 20 Feb 2026 · 23 likes Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether you lost a "meaningful" dose depends on concentration and your…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #81 · Practice › Dosing & titration · 19 Feb 2026 · 13 likes Everything in post #79 holds. The case it does not cover is the one I have. Concentration and dose get conflated constantly in this subcategory. Changing how much…
Reconstitution volumes that produce round numbers, tabulated Replied, post #49 · Practice › Reconstitution · 19 Feb 2026 · 0 likes Where I part company with post #45, and it is a narrow parting. Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing.…
Residual solvents and scavengers: what is looked for — what changed since Replied, post #8 · Analytics › Impurities & related substances · 16 Feb 2026 · 6 likes Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete…
[2026 update] Confounding by indication, explained with a concrete example Replied, post #23 · Evidence › Study critique · 3 Feb 2026 · 21 likes A run-in period that excludes non-responders before randomisation changes what the trial is estimating. It is legitimate design and it must be stated in any summary.…
Second pass at: What pooling buys you and what it destroys Replied, post #14 · Evidence › Meta-analyses · 1 Feb 2026 · 7 likes Fixed-effect and random-effects models answer different questions. The first assumes one true effect; the second assumes a distribution of them. Choosing between them…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #21 · Sourcing › Independent verification · 24 Jan 2026 · 0 likes I had written a reply contradicting post #17 and deleted it. Here is what survived. Two claims get bundled together under Janoshik and they need separating. The…
A widely repeated interaction claim that turns out to be unsupported Replied, post #19 · Practice › Interactions · 13 Jan 2026 · 0 likes Renal or hepatic impairment changes the calculus for a lot of combinations and is the context most often missing from an interaction question here. The claim is…
Muscle cramps: the ordinary causes before the exotic ones Replied, post #8 · Practice › Side effects · 12 Jan 2026 · 5 likes Constipation is reported at least as often as nausea and is discussed a fraction as much. Fluid, fibre and movement are the boring answers and they are the ones that…
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #58 · Regional › UK & Ireland · 11 Jan 2026 · 6 likes That matches what I have seen, for whatever a single anecdote is worth.
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #47 · Regional › UK & Ireland · 8 Jan 2026 · 8 likes Occupational health screening: some UK occupations require medical checks. Disclosure of weight-loss medication might be relevant to employment screening; understand…
Reverse causation in a cohort study of weight and outcome Replied, post #2 · Evidence › Study critique · 25 Dec 2025 · 16 likes Reverse causation is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
Research-use-only labelling: what it means and what it does not Replied, post #76 · Sourcing › Regulatory · 22 Dec 2025 · 0 likes Post #74 is right about the mechanism and I think understates the practical bit. Research-use-only material is not approved for human use anywhere. That is a statement…
Gastro-oesophageal reflux: improving or worsening? Replied, post #4 · marked as the solution · Clinical › Comorbidities · 11 Dec 2025 · 11 likes Two questions I would want answered before drawing anything from the gastro-oesophageal reflux data above: how were the cases selected, and what happened to the ones…
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #11 · Compounds › Oral incretins · 11 Dec 2025 · 9 likes The practical argument for an oral is adherence, and the published adherence data is less flattering than the argument. Daily dosing with fasting requirements is not…
Second pass at: Metformin co-administration and additive GI effects Replied, post #14 · Practice › Interactions · 5 Dec 2025 · 0 likes Narrowing post #11, because the general version has more than one answer. The most defensible general position in this subcategory: identify the plausible mechanism,…
Follow-up: Constipation management, with a dietitian's contribution Replied, post #36 · Practice › Side effects · 27 Nov 2025 · 10 likes The failure mode on Constipation management is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to…
The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset Replied, post #8 · Compounds › Tirzepatide · 26 Nov 2025 · 3 likes Useful. I have added it to my own notes with the date on it.
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #31 · Compounds › Other compounds · 23 Nov 2025 · 0 likes A compound with no established assay is a compound where a certificate can say almost anything. That is not an accusation about anyone; it is a statement about what a…
Heterogeneity as information rather than as a nuisance Started this topic · Evidence › Meta-analyses · 14 Nov 2025 · 2 likes Posting this under the heading it deserves: Heterogeneity as information rather than as a nuisance Everything below is what sits behind that. An honest uncertainty…
[2026 update] What steady state means for the decision to escalate Replied, post #23 · Practice › Dosing & titration · 7 Nov 2025 · 8 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #32 · Compounds › Oral incretins · 6 Nov 2025 · 32 likes Where I part company with post #30, and it is a narrow parting. On variability: the between-person spread in exposure for oral semaglutide is wide enough that two…
Second pass at: Programming during a large energy deficit Replied, post #67 · Nutrition & Training › Resistance training · 4 Nov 2025 · 0 likes Narrowing post #64, because the general version has more than one answer. Adding what did not work for me on Programming during a large energy, since the failures never…
Reconciling a supplier certificate with an independent result Replied, post #22 · Sourcing › Vendor reports · 4 Nov 2025 · 13 likes Reconciling a supplier certificate is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #156 · Practice › Reconstitution · 31 Oct 2025 · 1 like Reconstituting the whole vial when you will use a quarter of it is a decision to store the rest in solution, which is the least stable state it will ever be in.…
Pooling trials with different estimands — what changed since Replied, post #44 · Evidence › Meta-analyses · 30 Oct 2025 · 0 likes Careful with the language on Pooling trials with different estimands. "Not detected" and "not present" are different findings and the first is a statement about the…
Sleep tracking data and its considerable limitations Replied, post #70 · Wellbeing › Sleep · 23 Oct 2025 · 0 likes Energy and sleep needs: rapid weight loss increases real metabolic stress. Sleep needs might increase even though appetite for food has decreased. Prioritising sleep is…
Publishing an inconvenient result: a case study — the long version Replied, post #15 · Sourcing › Independent verification · 21 Oct 2025 · 16 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want. I checked…
Payment mechanics and the recovery options that do not exist Replied, post #2 · Sourcing › Payments · 18 Oct 2025 · 0 likes Speaking only to payment mechanics as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and…
Follow-up: Why appetite effects are mostly central Replied, post #65 · Pharmacology › Receptor biology · 12 Oct 2025 · 3 likes Glucose dependence is the property that distinguishes incretin-mediated insulin secretion from a sulfonylurea. It is also why hypoglycaemia risk from these compounds…
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #9 · Practice › Storage & stability · 8 Oct 2025 · 15 likes Worth separating two things that post #7 runs together. Dry storage in a freezer is generally more protective than a refrigerator for long periods, provided the…
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #26 · Compounds › Cagrilintide & amylin analogues · 2 Oct 2025 · 2 likes The arithmetic in post #23 is right; the assumption feeding it is the part to check. The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for…
When a preprint is the best available evidence and we say so Replied, post #132 · Evidence › Preprints · 3 Sep 2025 · 0 likes Worth separating two things that post #128 runs together. Where a preprint's numbers are the basis of a claim being repeated here, someone should check whether the…
Pinch or no pinch, and how needle length changes the answer Replied, post #23 · Practice › Administration · 17 Aug 2025 · 5 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #40 · Compounds › Semaglutide · 11 Aug 2025 · 0 likes Post #38 is right about the mechanism and I think understates the practical bit. Discontinuation rates in the trials are worth reading alongside efficacy and almost…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #6 · Evidence › Journal club · 7 Aug 2025 · 30 likes On post #2 — agreed on the reasoning, with one qualification. The confident answers on orforglipron phase 2 and the well-sourced answers are not the same answers, which…
Follow-up: History of disordered eating and why it changes the conversation Replied, post #54 · Clinical › Special populations · 5 Aug 2025 · 15 likes Post #52 is the version of this I will quote in future. One addition. Practical note on History of disordered eating: write down what you expect before you look. The…
A ten-fold dose error caught before injection — one year on Replied, post #118 · Devices › Syringes & needles · 4 Aug 2025 · 0 likes Where I part company with post #117, and it is a narrow parting. Buying a box of the wrong barrel size is the most common regret described in this subcategory, and the…
Thyroid function tests during substantial weight change Replied, post #14 · Clinical › Bloodwork · 26 Jul 2025 · 0 likes Add biological variation and analytical imprecision to that base rate and the probability of a meaningless flag on a multi-analyte panel is substantial. This has been…
The C-cell question: rodent findings and their human context Replied, post #43 · Compounds › Semaglutide · 26 Jul 2025 · 15 likes Careful with the language on c-cell question. "Not detected" and "not present" are different findings and the first is a statement about the method.
Counter-ion content and its effect on measured mass Replied, post #95 · Analytics › Mass spectrometry · 18 Jul 2025 · 21 likes Post #91 and I disagree about the size of the effect, not about the direction. Counter-ion content sits at the boundary between what this community can usefully discuss…
Substitution between formats during a shortage Replied, post #24 · Access › Shortages · 17 Jul 2025 · 18 likes Small methodological point on substitution between formats: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Subcutaneous absorption kinetics and site differences Replied, post #13 · Pharmacology › Pharmacokinetics · 5 Jul 2025 · 0 likes I have been on both sides of the subcutaneous absorption kinetics and site argument in this category within eighteen months, which should tell you how strong the…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #74 · Compounds › Retatrutide · 4 Jul 2025 · 0 likes Adding the measurement that post #71 says would settle it. Source for the Triple agonism figure, since it was asked for. It is in the discussion rather than the…
Interim analyses and stopping rules — does this still hold? Replied, post #22 · Evidence › Trials · 1 Jul 2025 · 1 like I had read the opposite somewhere and cannot now find where, which tells me something.
Hepatic steatosis: what the MASH trial evidence supports Replied, post #72 · Clinical › Comorbidities · 23 Jun 2025 · 11 likes Worth separating two things that post #69 runs together. Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #56 · Evidence › Trials · 18 Jun 2025 · 0 likes Pre-specification is the property that makes a primary endpoint trustworthy. An endpoint chosen after seeing the data can be the best endpoint in the world and it no…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #90 · Practice › Reconstitution · 12 Jun 2025 · 7 likes Same experience here, different supplier, so it is at least not unique to one of them.
[2026 update] Dose numbers across compounds are not on the same scale Replied, post #17 · Practice › Dosing & titration · 9 Jun 2025 · 5 likes Post #15 put the caveat in the right place and I want to underline it. Dose and effect are not linear across the studied range for every compound in this class.…
What a documentation review can and cannot tell you Replied, post #2 · Sourcing › Independent verification · 9 Jun 2025 · 23 likes The opening post describes the usual case. This is about the unusual one. I would call the community position on documentation review likely rather than established,…
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #29 · Compounds › Cagrilintide & amylin analogues · 6 Jun 2025 · 0 likes Understood. Thank you for being specific about the limits of it.
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #17 · Evidence › Trials · 6 Jun 2025 · 5 likes Registration before enrolment, with the primary endpoint declared, is what makes outcome switching detectable. Checking the registry against the paper takes five…
Reading a regulatory notice rather than an article about it — what changed since Replied, post #14 · Sourcing › Regulatory · 6 Jun 2025 · 0 likes A label change is a regulatory event with a date and a document. Citing the document is what makes a claim about labelling checkable. The reasoning is more useful than…
Coming back to: Getting a referral rather than a refusal Replied, post #31 · Clinical › Prescriber conversations · 4 Jun 2025 · 10 likes The bit of Getting a referral that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread…
Follow-up: What other technical communities get right that we do not Replied, post #112 · Lounge › Off topic · 28 May 2025 · 0 likes Unserious but true: I can now identify a certificate template at a glance and I have no professional use for that skill whatsoever. Adding it because I spent an…
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #48 · Sourcing › Independent verification · 27 May 2025 · 2 likes The most useful thing anyone has posted about splitting a vial in this category was a table of what had been measured and by whom. That is what I would want again.
Second pass at: Semaglutide and alcohol: what is actually documented Replied, post #5 · Compounds › Semaglutide · 23 May 2025 · 7 likes On the opening post — agreed on the reasoning, with one qualification. The 2.4 mg maintenance dose in the weight-management programme and the 1.0 mg diabetes dose are…
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #41 · Evidence › Journal club · 18 May 2025 · 24 likes A conflict-of-interest statement is worth reading aloud and is worth very little as a predictor. Design quality is what to spend the session on.
Storing a pen in use versus a pen unopened Replied, post #14 · Devices › Pens & autoinjectors · 16 May 2025 · 0 likes Off-label dosing with a pen: if you want to deliver a dose different from the pen's pre-set steps (e.g., halfway between two step doses), that is off-label use. Some…
DXA precision and the least significant change for lean mass — the long version Replied, post #18 · Outcomes › Body composition · 8 May 2025 · 25 likes Preserving lean tissue during a substantial deficit depends on protein intake and a resistance stimulus, and the evidence for both is reasonably strong.
Why we hide unevidenced fraud accusations and log the hiding Replied, post #90 · Sourcing › Red flags · 4 May 2025 · 9 likes Noted, and I have changed what I was going to do on the strength of it.
Ipamorelin selectivity claims and where they came from — a second dataset Replied, post #2 · Compounds › Secretagogues & GH axis · 30 Apr 2025 · 27 likes Ipamorelin is usually described as selective in that it produces less of an effect on cortisol and prolactin than earlier compounds in the family. Selective is a…
A ten-fold dose error caught before injection Replied, post #21 · Devices › Syringes & needles · 15 Apr 2025 · 30 likes Everything in post #20 holds. The case it does not cover is the one I have. A note on scope: what I am saying about ten-fold dose error caught applies to the case in…
Retatrutide dose escalation in the published trials Replied, post #117 · Compounds › Retatrutide · 11 Apr 2025 · 0 likes Taking post #116 at face value and following it one step further. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is…
Anxiety in the first weeks: drug, situation, or both Replied, post #72 · Wellbeing › Mental health · 8 Apr 2025 · 16 likes This follows post #69 rather than contradicting it. Tracking mood alongside dose and weeks, on a simple scale, produces a record that is far more useful than a…
Carryover and the ghost peak from last week's standard Replied, post #33 · Analytics › HPLC & UHPLC · 5 Apr 2025 · 5 likes I had written a reply contradicting post #29 and deleted it. Here is what survived. Detection at 214 nanometres sees the peptide bond and therefore sees almost…
Requesting a page: what makes a good request Replied, post #40 · Documentation › Wiki requests · 31 Mar 2025 · 8 likes A request is more likely to succeed with a proposed outline attached. "Somebody should write about X" rarely moves; a structure and two sections does. Two sources, same…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #102 · Compounds › Semaglutide · 15 Mar 2025 · 10 likes Narrowing post #99, because the general version has more than one answer. On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with…
Biased agonism: a real phenomenon, an over-used explanation Replied, post #84 · Pharmacology › Receptor biology · 12 Mar 2025 · 11 likes I had read the opposite somewhere and cannot now find where, which tells me something.
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #48 · Evidence › Journal club · 27 Feb 2025 · 17 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions. The uncertainty…
Coming back to: Official shortage notices and what they authorise Replied, post #21 · Access › Shortages · 16 Feb 2025 · 27 likes On post #19 — agreed on the reasoning, with one qualification. Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap…
Why mass spectrometry cannot tell you about an epimer Replied, post #59 · Analytics › Mass spectrometry · 16 Feb 2025 · 14 likes Before the thread moves on from mass spectrometry — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of…
Reading a chromatogram someone posted without axes Replied, post #3 · Analytics › HPLC & UHPLC · 13 Feb 2025 · 4 likes An update on my earlier reading a chromatogram post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
When "no data" is the complete and final answer Replied, post #76 · Compounds › Other compounds · 26 Jan 2025 · 11 likes Building on post #73 rather than restating it. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a…
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #53 · Analytics › COA interpretation · 25 Jan 2025 · 0 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #122 · Access › Insurance & coverage · 15 Jan 2025 · 17 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
Oxidation pathways for methionine and tryptophan Replied, post #14 · Analytics › Impurities & related substances · 26 Dec 2024 · 15 likes That is the distinction I keep failing to hold on to. Written down now.
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #70 · Compounds › Semaglutide · 25 Dec 2024 · 4 likes If someone has run Semaglutide half-life properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
Turnaround times and what they mean for a decision — one year on Replied, post #23 · Sourcing › Independent verification · 21 Dec 2024 · 23 likes Worth separating Turnaround times as a question about the compound from Turnaround times as a question about the documentation. They get answered by different people…
Why mass spectrometry cannot tell you about an epimer Started this topic · Analytics › Mass spectrometry · 7 Dec 2024 · 0 likes Why mass spectrometry cannot tell you about an epimer I have a specific reason for asking rather than idle curiosity, and the context is below. I have spent a fortnight…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #134 · Compounds › Repair & healing peptides · 24 Nov 2024 · 6 likes The pentadecapeptide sequence is short and stable enough to survive conditions that would degrade a larger peptide, which is one of the few things about it that is well…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #51 · Compounds › Tirzepatide · 23 Nov 2024 · 2 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #37 · Access › Insurance & coverage · 22 Nov 2024 · 17 likes Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist…
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #21 · Practice › Reconstitution · 21 Nov 2024 · 13 likes Everything in post #17 holds. The case it does not cover is the one I have. If your arithmetic gives a volume smaller than one graduation on your syringe, the answer is…
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #13 · Nutrition & Training › Protein & intake · 20 Nov 2024 · 0 likes Where intake has fallen a long way, protein is usually the first thing to fall because it is the least appealing macronutrient when appetite is reduced.
Coming back to: Preparing for an appointment: one page, three questions Replied, post #103 · Clinical › Prescriber conversations · 19 Nov 2024 · 5 likes Nothing here is medical advice, and this subcategory exists to help people ask better questions rather than to answer them. I would treat the number as indicative…
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #2 · Devices › Syringes & needles · 15 Nov 2024 · 8 likes Gauge and length selection came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
When "no data" is the complete and final answer Replied, post #21 · Compounds › Other compounds · 15 Nov 2024 · 17 likes Post #20 is the version of this I will quote in future. One addition. How to research a compound with no human data: mechanistic plausibility is one input. Preclinical…
Anxiety in the first weeks: drug, situation, or both Replied, post #9 · Wellbeing › Mental health · 18 Oct 2024 · 26 likes Picking up post #7: that is the part I would want checked first. Support and community: some people process weight change through community (online or in-person).…
Requesting a page: what makes a good request — what changed since Replied, post #46 · Documentation › Wiki requests · 10 Oct 2024 · 1 like Name a willing maintainer in the request. Point three of the criteria stops more nominations than the other three combined. A qualification I should have led with…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #96 · Sourcing › Independent verification · 29 Sep 2024 · 28 likes Where two services agree with each other and with the declared figure, that is a genuinely strong result and it applies to that lot. Small point, but it is the one that…
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #15 · Practice › Side effects · 20 Sep 2024 · 0 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #42 · Evidence › Journal club · 13 Sep 2024 · 9 likes Post #40 describes the usual case. This is about the unusual one. The number people quote for SURPASS-2 is a central estimate presented without its interval, and the…
The C-cell question: rodent findings and their human context — what changed since Replied, post #42 · Compounds › Semaglutide · 8 Sep 2024 · 13 likes My experience of c-cell question contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #8 · Clinical › Bloodwork · 3 Sep 2024 · 0 likes This follows post #7 rather than contradicting it. The claim about bring a laboratory upthread is stronger than its source supports. I have read the source. The source…
The topic list is dense — is that deliberate? Replied, post #9 · Meta › Site feedback · 30 Jul 2024 · 23 likes I disagree with the framing of topic list above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be checked.…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #9 · Nutrition & Training › Hydration & electrolytes · 22 Jul 2024 · 0 likes Everything in post #5 holds. The case it does not cover is the one I have. Reading this Sodium thread as someone who came in with a fixed view: the third and seventh…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #103 · Practice › Dosing & titration · 9 Jul 2024 · 0 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
Cold packs, phase-change material, and what survives ten days Replied, post #87 · Sourcing › Logistics · 9 Jul 2024 · 11 likes Adding a small correction to the cold packs summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that matters.